Star Team 2020 Group Company Advanced Civilization Team Shizhen Pavilion Pharmacy Day
Release time:
2021-11-22
2021 9# March 2 is a normal day for Shijange Pharmacy, a big pharmacy.
7: 10 , with 20 minutes before the summer camp time, cashier Su Kelly has already arrived at the store. Open the door, enter the store, turn on the light, change work clothes, a recording horn was hung on the door handle by her, and began to repeat: "Please cooperate to wear a mask, show your health code, and take your temperature." This has been the background sound of pharmacy work during the new crown epidemic.
7: 15-7 : 20 , the morning shift clerks went to the store one after another, changed into work clothes, opened the two doors of the south and north, and Shizhen Pavilion entered the working mode. All business preparations must be done before the end of the day. This is a fixed process of Shizhen Pavilion.
7: 24 , Shizhen Pavilion welcomed the first customer of the day. After measuring the temperature and checking the code, the guest went straight to the Minsheng Pharmaceutical Service Station, which turned out to be an early blood sugar test.
Around 28 8 in the morning, it is the busiest time of the day in Shizhen Pavilion, and most of the customers are middle-aged and elderly people. Most of them measure blood sugar and blood pressure before and after meals. The clerk in charge of the service station operates the instrument, while asking about living habits, giving health advice, how did you sleep, what to eat, how much to eat at each meal, what to pay attention to at ordinary times... One item after another, he is as friendly and familiar as his family. Many of the people who came were regular customers, and the clerk could recognize them all the way-"Master Su is here, long time no see!" After many customers finished the test, they sat down beside them and chatted. 8
:30 , the passenger flow is gradually decreasing, and the cabinet is quiet again. Accompanied by the tireless instructions of the recording horn, the traditional Chinese medicine cooked for the customers has boiled, and the slightly bitter smell of medicine blooms in the air. The shop assistants were not idle, replenishing the medicine cabinets and sorting out and screening the medicines that were in the near-term.
In addition to the "morning peak" at8 , there are some strange rules in Shizhen Pavilion. Winter is busier than summer, the middle of each month is busier than the last ten days, and Monday is busier than Monday. Whenever he is busy, the clerk is like a spinning top, and he can't stop at all. "One thing in the east and one thing in the west, I feel that my brain is not enough". Like the manager of Chen Jing, he either measures the temperature and code at the cash register, or "guards the door" at the door, or takes medicine in the medicine cabinet, and often goes out to deliver medicine to customers. In addition to the work in the store, we must also care about the hygiene at the door. In addition to the "doorkeeper" staff, other people will take the initiative to help in other positions when there are no customers in their posts.
After communicating with the clerk, I realized that selling drugs is not as simple as "buying" and "selling. Drugs are special commodities related to health. Selling drugs is not a simple "give what the customer wants". How to judge what drugs the customer needs according to the description of the customer's symptoms, how to make the customer believe in himself, have a good experience in purchasing drugs, and can cure the disease after buying drugs. There are many ways. Some customers come with empty medicine boxes. This kind of pharmacy does not have or has stopped production. Suggestions for alternative drugs should be provided according to specific conditions. Some customers have a little knowledge of health knowledge, or listen to the wrong theory, the clerk will repeatedly explain or even refute the rumor... Compared with the young clerk, the oldest Master Zhou is quite "taking advantage", he has white hair, a look is an experienced old pharmacist, customers always subconsciously trust him more.In addition to receiving customers step by step, shop assistants will also encounter some "unexpected situations". Just the day before yesterday, an old woman fainted because her blood sugar was too low. Everyone called
120 and fed her quick-acting heart-saving pills and sugar water. Fortunately, there was no danger. Everyone is used to other things such as picking up customers' lost property and returning it to its original owner.
Of course, the biggest "emergency" is nothing more than the new coronary pneumonia epidemic. At the beginning of the outbreak last year, people snapped up health and epidemic prevention supplies, coupled with the reason that the relevant production capacity could not keep up, the market supply was extremely tight. During that time, the first thing Chen Jing did when he opened his eyes every day was to run to the warehouse to "rob materials". He did not dare to sell them openly even if he grabbed them, for fear that the goods behind him would not come in. It was only a little easier when the epidemic stabilized and the prevention and control process and material supply went smoothly. But in any case, pharmacies, as part of the medical industry, have been the focus of epidemic prevention and control to this day, and the specific requirements often change with the regional epidemic. There are several "checkpoints" such as bright code, temperature measurement, filling in forms and registering ID cards alone ". Cold medicine was originally a regular category in pharmacies. It has been banned for a long time because of the epidemic. After the epidemic is opened for sale, two epidemic prevention and control registration forms have to be filled in. The pharmacy is responsible for returning to visit customers whether they take medicine and whether their symptoms are relieved. The continuous adjustment of a variety of control requirements has brought a lot of pressure to the pharmacy, but the pharmacy has been working hard and has been trying its best to cooperate.For Shi Zhen Ge, in addition to the new crown epidemic, the most special situation last year should be to participate in the Jinhua city
4 round of health insurance chronic disease designated retail pharmacy tender. Speaking of this, Chen Jing used three words to evaluate, "very exciting".
Chronic disease drugs account for more than 40% of the turnover of Shizhen Pavilion, and all employees are determined to win the tender. At that time, the in-store system and the medical insurance system had not yet been connected, and more than 2,000 varieties of drug information, including types, manufacturers, specifications, quantities, dosage forms, etc., had to be manually entered into the medical insurance system. Hundreds of varieties will be added every time, and they must be checked repeatedly before and after each entry to ensure that there are no mistakes in the random inspection. There are a total of19 people in Shizhen Pavilion. They have to operate normally during the day. The entry work can only be done overtime at night. It is common to get up at 2 in the morning. They have to get up to work the next day. When time is tight, they even stay up all night several times.
With the attention of the company's leaders and the help of various departments, everything comes to him who waits. After more than ten days of hard work, Shizhen Pavilion successfully passed the tender, and a stone hanging in everyone's heart finally fell to the ground.21
:22 , the night is dark and the heat has faded. The shop assistants began to check accounts, tidy up the counter and mop the floor to finish the day. The recording speaker also completed its task, went down from the door handle to rest, and the pharmacy finally returned to real quiet. 21
:28 , a customer came to the store and left in a hurry. He was the last customer received by Shizhen Pavilion today. Behind him, the store slowly fell into a deep sleep, waiting for the next day to welcome new customers. (Reporter Chen Shengmu)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31